Picture of EKF Diagnostics Holdings logo

EKF EKF Diagnostics Holdings News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

REG - EKF Diagnostics Hldg - Result of AGM and Voting Results

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250520:nRST4567Ja&default-theme=true

RNS Number : 4567J  EKF Diagnostics Holdings PLC  20 May 2025

EKF Diagnostics Holdings plc

("EKF" or the "Company")

 

Result of AGM and Voting Results

 

EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed global diagnostics
business, announces that at its Annual General Meeting ("AGM") held earlier
today, all resolutions were duly passed.

 

The voting results of the AGM were as follows:

 

             For                                                                                     Against                                      Withheld
 Resolution  Votes                                                                           %       Votes                                %       Votes
 1                                                                                           99.98%                 75,000                0.02%                   1,500
             318,641,499
 2                                                                                           99.96%               133,585                 0.04%            8,522,075
             310,062,339
 3                                                                                           99.95%               147,659                 0.05%                   1,500
             318,568,840
 4                                                                                           99.73%               695,153                 0.27%          58,519,000
             259,503,846
 5                                                                                           99.85%               464,104                 0.15%                   2,128
             318,251,767
 6                                                                                           99.93%               214,684                 0.07%                   2,128
             318,501,187
 7                                                                                           99.96%               128,040                 0.04%                   1,500
             318,588,459
 8                                                                                           98.52%            4,707,814                  1.48%                   1,000
             314,009,185
 9                                                                                           99.97%                 95,431                0.03%                   1,000
             318,621,568
 10*                                                                                         99.96%               130,472                 0.04%                   1,500
             318,586,027
 11*                                                                                         99.34%            2,102,808                  0.66%                   3,628
             316,611,563
 12*                                                                                         83.92%          51,263,645                   16.08%                  3,628
             267,450,726
 13                                                                                          84.17%          49,194,657                   15.83%           7,968,110
             261,555,232

 

 

 EKF Diagnostics Holdings plc                                www.ekfdiagnostics.com (http://www.ekfdiagnostics.com)
 Julian Baines, Executive Chair                               via Walbrook PR
 Gavin Jones, Chief Executive Officer
                                                                                           Tel: +44 (0)20 7496 3000

 Singer Capital Markets (Nominated Adviser & Broker)
 Phil Davies / Oliver Platts

 Walbrook PR Limited              Tel: +44 (0)20 7933 8780 or ekf@walbrookpr.com (mailto:ekf@walbrookpr.com)
 Paul McManus / Alice Woodings    Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654

 

 

 

About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com
(http://www.ekfdiagnostics.com) )

 

EKF is an AIM-listed global diagnostics business focussed on:

 

 ●    Point-of-Care analysers in the key areas of Hematology and Diabetes
 ●    Life Sciences services provide specialist manufacture of enzymes and custom
      products for use in diagnostic, food and industrial applications.

 

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing
sites across the US and Germany, selling into over 120 countries world-wide.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGPKKBNNBKDFPB

Recent news on EKF Diagnostics Holdings

See all news